We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+594.2%
AUM
$50.6B
AUM Growth
+$8.03B
Cap. Flow
+$6.33B
Cap. Flow %
12.5%
Top 10 Hldgs %
27.21%
Holding
6,287
New
1,391
Increased
1,722
Reduced
1,856
Closed
1,277

Sector Composition

Rank Sector Weight
1 Communication Services 3.74%
2 Consumer Discretionary 3%
3 Technology 2.83%
4 Healthcare 1.26%
5 Consumer Staples 1.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGB
4926
Trekor Metals
TGB
$2.48B
$15K ﹤0.01%
+19,010
New +$15.9K
ATYR
4927
aTyr Pharma
ATYR
$47.6M
$15K ﹤0.01%
+1,338
New +$14.6K
GENE
4928
DELISTED
Genetic Technologies Ltd.
GENE
$15K ﹤0.01%
677
+38
+6% +$863
ONCS
4929
DELISTED
OncoSec Medical Incorporated
ONCS
$15K ﹤0.01%
+48
New +$14.8K
SLNG icon
4930
Stabilis Solutions
SLNG
$87.8M
$14K ﹤0.01%
2,476
-380
-13% -$3.17K
BYU
4931
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$14K ﹤0.01%
+14
New +$14.2K
IMBI
4932
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$13K ﹤0.01%
+1,090
New +$14.3K
BDR
4933
DELISTED
Blonder Tongue Laboratories Inc
BDR
$13K ﹤0.01%
+10,124
New +$13.1K
SKYS
4934
DELISTED
Sky Solar Holdings, Ltd.
SKYS
$13K ﹤0.01%
+7,463
New +$17.4K
HURA
4935
TuHURA Biosciences
HURA
$138M
$12K ﹤0.01%
+1
New +$10.8K
BLPH
4936
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$12K ﹤0.01%
+741
New +$17.6K
SNES icon
4937
SenesTech
SNES
$7.16M
-1
Closed -$51.4K
ALIM
4938
DELISTED
Alimera Sciences
ALIM
$11K ﹤0.01%
+769
New +$11.7K
CFMS
4939
DELISTED
Conformis, Inc. Common Stock
CFMS
$11K ﹤0.01%
404
-1,700
-81% -$46.2K
YGTY
4940
DELISTED
SSLJ.com Limited Class A Ordinary Shares
YGTY
$11K ﹤0.01%
+2,889
New +$19.1K
NAVB
4941
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$11K ﹤0.01%
+2,335
New +$8.85K
ALO
4942
DELISTED
Alio Gold Inc
ALO
$10K ﹤0.01%
12,360
-3,400
-22% -$3.54K
CRVO icon
4943
CervoMed
CRVO
$23.9M
$8K ﹤0.01%
+17
New +$7.91K
AUMN
4944
DELISTED
Golden Minerals Company
AUMN
$8K ﹤0.01%
1,597
+107
+7% +$699
FABC
4945
Fabric.AI Inc
FABC
$16.6M
$6K ﹤0.01%
+3
New +$10.5K
AGRX
4946
DELISTED
Agile Therapeutics
AGRX
$6K ﹤0.01%
+8
New +$5.86K
KPRX icon
4947
Kiora Pharmaceuticals
KPRX
$11.3M
$5K ﹤0.01%
+3
New +$8.06K
XPL icon
4948
Solitario Resources
XPL
$68.3M
$5K ﹤0.01%
+12,874
New +$5.02K
NEON icon
4949
Neonode
NEON
$14.1M
$4K ﹤0.01%
1,061
-903
-46% -$2.95K
ICON
4950
DELISTED
Iconix Brand Group, Inc.
ICON
$4K ﹤0.01%
1,157
-24,070
-95% -$109K

Similar funds

Jane Street's Q3 2018 Portfolio in Review

As of Q3 2018, Jane Street held 6,287 positions worth $50.6B, up 19% from $42.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jane Street deployed $6.33B of net new capital in Q3 2018, opening 1,391 new positions and adding to 1,722 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 6,735,271 shares worth $288M.

By sector, the portfolio is most concentrated in Communication Services at 3.7% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $513M trimmed.

  • Jane Street's largest Q3 2018 buy was iShares China Large-Cap ETF: 6,735,271 shares worth $288M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $794M increase.
  • Jane Street's biggest Q3 2018 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $513M.
  • Jane Street fully exited Vanguard FTSE Developed Markets ETF in Q3 2018, selling an estimated $215M.
  • Jane Street's ten largest holdings make up 27% of its $50.6B portfolio in Q3 2018.
  • Jane Street opened 1,391 new positions and closed 1,277 in Q3 2018.
  • Jane Street's portfolio value rose 19% quarter-over-quarter to $50.6B.

Based on Jane Street's 13F filing for Q3 2018, filed 14 Nov 2018.